Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Ultrasound ; 31(2): 84-90, 2023 May.
Artigo em Inglês | MEDLINE | ID: mdl-37144232

RESUMO

Introduction: MicroUS is a new imaging technique that may have potential to reliably monitor prostate disease and therefore release capacity in MRI departments. Firstly, however, it is essential to identify which healthcare staff may be suitable to learn to use this modality. Based on previous evidence, UK sonographers may be well placed to harness this resource. Topic: Currently, there is sparse evidence on the performance of MicroUS for monitoring prostate disease but early findings are encouraging. Although its uptake is increasing, it is believed that only two sites in the UK have MicroUS systems and only one of those uses just sonographers to undertake and interpret this new imaging technique. Discussion: UK sonographers have a history of role extension dating back several decades and have proven repeatedly that they are reliable and accurate when measured against a gold standard. We explore the background of UK sonographer role extension and postulate that sonographers are best placed to adopt and embed new imaging techniques and technology into routine clinical practice. This is of particular importance given the dearth of ultrasound focussed radiologists in the UK. To effectively introduce challenging new work streams, multi-professional collaboration in imaging, alongside sonographer role extension, will ensure precious resources are maximised thus ensuring optimum patient care. Conclusion: UK sonographers have repeatedly demonstrated reliability in many areas of role extension in various clinical settings. Early data indicate that the adoption of MicroUS for use in prostate disease surveillance may be another role suited to sonographers.

2.
Ultrasound ; 29(4): 207, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-34777540
3.
Ultrasound ; 29(3): 139, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-34567224
4.
Ultrasound ; 29(2): 72, 2021 May.
Artigo em Inglês | MEDLINE | ID: mdl-33995552
5.
Ultrasound ; 29(1): 3, 2021 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-33552221
6.
Ultrasound ; 28(3): 135, 2020 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-32831885
7.
Ultrasound ; 28(2): 67, 2020 May.
Artigo em Inglês | MEDLINE | ID: mdl-32528542
8.
Ultrasound ; 28(1): 3, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-32063988
9.
Ultrasound ; 28(4): 207, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-36959896
10.
Ultrasound ; 26(2): 93-100, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-30013609

RESUMO

Detection rates of congenital cardiac malformations have traditionally remained low. The NHS Fetal Anomaly Screening Programme (FASP) aims to increase these detection rates for various reasons, including influencing perinatal management and aiding parental decision making. The inclusion of the three vessel view and trachea (3VT) view in 2015 aimed to improve detection rates of arch abnormalities in particular. This study evaluated the early impact of the new initiative at one NHS Trust. Departmental screen-positive rates were compared for a full year before and after implementation. Referrals to, and opinions of, the foetal medicine unit (FMU) were assessed; as were undetected congenital heart defects for the two time periods. Compared with the pre-implementation (pre-3VT) period, the number of completed anomaly scans performed after implementation (post-3VT) increased by 3% and the number of FMU referrals increased by 625%. Departmental screen-positive rates for cardiac abnormalities increased from 40% (pre-3VT) to 91% (post-3VT). Over half (52%) of the FMU referrals were made due to a suspected abnormal 3VT view. Early evaluation of 3VT implementation at this NHS Trust indicates that it has been a success. Departmental screen-positive rates for congenital cardiac malformations have risen. However, this performance has come at a cost: Some abnormalities now being detected, such as loose vascular ring and PLSVC, are frequently asymptomatic and likely to be clinically insignificant. The implementation of 3VT achieves the aims of FASP but may begin to exceed what is expected from a low risk population screening programme.

11.
Ultraschall Med ; 39(1): e1, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-29495062
12.
Ultraschall Med ; 39(1): 94, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-29415304
14.
Ultrasound ; 22(1): 57-60, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27433194

RESUMO

It is essential for the management of the patient that ultrasound practitioners produce reports based on their examinations that are accurate and clear. Ideally, all reports should attempt to answer the original clinical question. This seems a simple requirement and yet it is not always as easy as it sounds. In this paper, we explore the importance of the report, reasons that give rise to poor report writing and suggest educational resources that are available to improve poor report writing. Common mistakes and language ambiguity are discussed. Finally, we suggest a simple five-point framework, which practitioners may find useful when constructing ultrasound reports.

15.
Ultrasound ; 22(2): 126-8, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-27433207

RESUMO

This case study discusses a recent diagnosis of a rare form of ectopic pregnancy within a Caesarean section scar. Evidence indicates that the prevalence of this form of ectopic pregnancy is escalating due to the increasing number of Caesarean sections performed. As ultrasound plays a major role in diagnosing this rare life-threatening condition, we recommend key points for practitioners to consider for meticulous assessment and accurate diagnosis.

16.
Mov Disord ; 24(1): 115-8, 2009 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-19006068

RESUMO

Apomorphine hydrochloride is a dopamine agonist used in the treatment of advanced Parkinson's disease. Its administration by subcutaneous infusions is associated with the development of nodules that may interfere with absorption of the drug. This pilot study assessed the effectiveness of ultrasound (US) in the treatment of these nodules. Twelve participants were randomly assigned to receive a course of real or sham US on an area judged unsuitable for infusion. Following treatment, no significant change was observed in measures of tissue hardness and tenderness. However, 5 of 6 participants receiving real US rated the treated area suitable for infusion compared with the 1 of 6 receiving sham US. Sonographic appearance improved in both groups, but more substantially in the real US group. Power calculations suggest a total sample size of 30 would be required to establish statistical significance. A full-scale study of the effectiveness of therapeutic US in the treatment of apomorphine nodules is warranted.


Assuntos
Antiparkinsonianos/efeitos adversos , Apomorfina/efeitos adversos , Agonistas de Dopamina/efeitos adversos , Toxidermias/terapia , Terapia por Ultrassom , Idoso , Antiparkinsonianos/uso terapêutico , Apomorfina/uso terapêutico , Agonistas de Dopamina/uso terapêutico , Toxidermias/etiologia , Feminino , Dureza , Humanos , Infusões Parenterais/efeitos adversos , Masculino , Pessoa de Meia-Idade , Doença de Parkinson/tratamento farmacológico , Projetos Piloto , Tamanho da Amostra , Tela Subcutânea/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA